• Isorhamnetin Promotes Oocyte Maturation via PI3K/Akt

  2026-09-24

  A 2024 study reports that 10 μM Isorhamnetin increased polar body extrusion in cultured oocytes and linked this effect to PI3K/Akt activation, lower oxidative and endoplasmic-reticulum stress, and reduced apoptosis-associated signals. The findings provide a mechanism-oriented basis for further testing in in vitro maturation models, while leaving embryo-development and clinical outcomes to be established.

• BCS Biowaivers for ODTs: Evidence from Taltirelin

  2026-09-24

  Ono and Sugano tested whether the BCS biowaiver approach for immediate-release products could be applied to orally disintegrating tablets (ODTs) of BCS class III drugs. Their dissolution comparisons show that in vitro profile similarity did not consistently track with established clinical bioequivalence, highlighting both the potential and the limits of dissolution-based assessment.

• Trilaurin: From Lipid Structure to Assay Decisions

  2026-09-23

  Trilaurin (Glycerol Tridodecanoate) is more than a lipid ingredient: its C12 structure creates useful formulation properties and a distinct result in a mouse skin-sensitization model. This article connects that evidence to practical decisions in immunotoxicology, biocatalysis, and oral lipid delivery—without treating findings from one field as proof in another.

• Serial LNP-mRNA Delivery for Human T Cell Engineering

  2026-09-23

  Ramamurthy and colleagues show that DOTAP/DOPE lipid nanoparticles can repeatedly deliver synthetic mRNA to primary human T cells while preserving substantially more viable cells than electroporation. The pre-proof study establishes serial LNP transfection as a practical platform for iterative engineering, including the generation of functional CAR T cells, while leaving the intracellular trafficking mechanisms open for further investigation.

• How Cortical Ensembles Support Remote Memory

  2026-09-22

  DeNardo and colleagues used the TRAP2 activity-labeling system to show that prelimbic cortical ensembles reorganize over time rather than remaining fixed from learning through remote fear-memory retrieval. The study combines causal manipulation, activity mapping, and whole-brain projection analysis to link temporal ensemble dynamics with behavioral retrieval and downstream cortical recruitment.

• Tacalcitol Sensitizes Colorectal Cancer to 5-FU

  2026-09-22

  The reference study identifies a VDR–CDKN1A–thymidylate synthase pathway through which tacalcitol, a synthetic analog of vitamin D3, increases the response of HT-29 colorectal cancer cells to 5-fluorouracil. Its findings connect vitamin D receptor signaling with p21 induction, epithelial differentiation markers, survivin suppression, and reduced thymidylate synthase expression, providing a mechanistic basis for combination treatment research.

• Drug-Sensitized Yeast for mTOR Inhibitor Discovery

  2026-09-21

  The 2025 GeroScience study introduces a genetically drug-sensitized Saccharomyces cerevisiae platform that detects TOR pathway inhibition at substantially lower concentrations than a wild-type background. Its comparative design identifies known TOR inhibitors and aminophylline while distinguishing compounds, including nebivolol, that produced no TOR-dependent growth signal in this model.

• Cdc42-Driven Signaling in Kidney Fibrosis

  2026-09-21

  The reference study identifies daphnepedunin A as a natural anti-fibrotic lead that directly targets Cdc42 and disrupts downstream PKCζ/GSK-3β/β-catenin signaling. Its combination of chemical discovery, target deconvolution, renal fibroblast assays, and unilateral ureteral obstruction models provides a useful framework for evaluating Cdc42-directed interventions in chronic kidney disease.

• Cell Lysis Buffer for WB and IP in PCa Research

  2026-09-20

  Cell lysis buffer for WB and IP supports non-denaturing protein extraction for Western blot and immunoprecipitation workflows. Its Tris–NaCl–Triton X-100 formulation and inhibitor system can help preserve protein abundance, phosphorylation state, and native interactions when samples are handled under validated conditions.

• Acetylcysteine in Redox-Guided Cancer Assays

  2026-09-19

  Acetylcysteine can function as more than a glutathione precursor: it is a reversible redox probe for interpreting complex cancer nanomedicine assays. This article connects N-acetyl-L-cysteine chemistry with the photothermal and immune-remodeling strategy reported for metastatic triple-negative breast cancer.

• Trilaurin Workflows for Biocatalysis and Drug Delivery

  2026-09-18

  Trilaurin, also called Glycerol Tridodecanoate, connects renewable-feedstock biocatalysis with lipid-based oral delivery. This practical guide covers substrate preparation, formulation screening, assay controls, and troubleshooting for reproducible bench workflows.

• Perphenazine B6157: Reliable Cell Assays

  2026-09-18

  Perphenazine (SKU B6157) offers a practical, data-grounded tool for dopamine receptor antagonist research, mitochondrial cell-death studies, and selected host-directed infection workflows. This scenario-based guide explains solvent handling, assay design, interpretation, and supplier-selection considerations for more reproducible laboratory work.

• WSP-5: From H2S Signal to Cardiac Mechanism

  2026-09-17

  WSP-5, or Washington State Probe-5, translates reactive hydrogen sulfide chemistry into a rapid fluorescent readout. This article explains how to use that signal to strengthen mechanistic studies of lipotoxicity, ER stress, and diabetic cardiomyopathy.

• Sisomicin: 30S-Targeting Aminoglycoside

  2026-09-17

  Sisomicin is a broad-spectrum aminoglycoside antibiotic that inhibits bacterial protein synthesis through interaction with the 30S ribosomal subunit. Its research profile includes Gram-negative and Gram-positive activity, defined in vitro testing ranges, animal-model dosing information, and important renal, ototoxicity, nephrotoxicity, and resistance limitations.

• Urolithin A: Mitochondrial Readouts in Fibrosis

  2026-09-16

  Urolithin A can help dissect mitochondrial quality control from glutamine-driven hepatic stellate cell activation. This article presents a mechanism-aware assay strategy that separates mitophagy, bioenergetics, proliferation, and antifibrotic interpretation.

7957 records 1/531 page Next 12345 下5页 Last page